Urine TWEAK level as a biomarker for early response to treatment in active lupus nephritis: a prospective multicentre study

Urine TWEAK level as a biomarker for early response to treatment in active lupus nephritis: a prospective multicentre study

Background TNF-like weak inducer of apoptosis (TWEAK) is a proinflammatory molecule that plays a key role in active inflammation of lupus nephritis (LN). Urine TWEAK (uTWEAK) levels were found to be associated with renal disease activity among patients with LN. Here, we determined whether serial mea...

Full description

Saved in:
Bibliographic Details
Main Authors: Thitima Benjachat Suttichet, Wonngarm Kittanamongkolchai, Chutipha Phromjeen, Sirirat Anutrakulchai, Thanachai Panaput, Atiporn Ingsathit, Nanticha Kamanamool, Vuddhidej Ophascharoensuk, Vasant Sumethakul, Yingyos Avihingsanon
Format: Article
Language:English
Published: BMJ Publishing Group 2019-12-01
Series:Lupus Science and Medicine
Online Access:https://lupus.bmj.com/content/6/1/e000298.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://lupus.bmj.com/content/6/1/e000298.full

Similar Items